"They (each of the generic drug makers) may be trying to cut a deal with Purdue Pharma so they can be the first generic to get in," said Greeley, a specialist in patent law. "Whoever gets first entry into the market can make a lot of money."

Read more:  http://www.stamfordadvocate.com/news/article/...z2KEBlsI9d